Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.0610
-0.4390 (-87.80%)
At close: Aug 13, 2026

Mosaic ImmunoEngineering Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
000.120.160.220.23
Cash & Short-Term Investments
000.120.160.220.23
Cash Growth
-99.95%-96.85%-26.35%-29.22%-2.43%-40.55%
Prepaid Expenses
00.020.030.020.040.04
Total Current Assets
00.020.140.180.260.27
Total Assets
00.020.140.180.260.27

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.180.130.130.120.130.11
Accrued Expenses
5.775.525.034.443.561.94
Short-Term Debt
0.20.20.2---
Other Current Liabilities
0.180.180.180.180.220.28
Total Current Liabilities
6.336.035.544.733.922.33
Long-Term Debt
1.51.471.391.321.230.74
Total Liabilities
7.837.56.936.055.153.07

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
2.052.052.052.052.021.73
Retained Earnings
-9.88-9.53-8.84-7.92-6.91-4.53
Total Common Equity
-7.83-7.48-6.79-5.87-4.88-2.8
Shareholders' Equity
-7.83-7.48-6.79-5.87-4.88-2.8
Total Liabilities & Equity
00.020.140.180.260.27

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1.71.671.591.321.230.74
Net Cash (Debt)
-1.7-1.66-1.48-1.16-1.01-0.51
Net Cash Growth
------
Net Cash Per Share
-0.24-0.23-0.20-0.16-0.14-0.08
Filing Date Shares Outstanding
7.247.247.247.247.247.24
Total Common Shares Outstanding
7.247.247.247.247.247.24
Working Capital
-6.33-6.01-5.4-4.55-3.66-2.06
Book Value Per Share
-1.08-1.03-0.94-0.81-0.67-0.39
Tangible Book Value
-7.83-7.48-6.79-5.87-4.88-2.8
Tangible Book Value Per Share
-1.08-1.03-0.94-0.81-0.67-0.39